Влияние аллореактивности естественных киллерных клеток на эффективность аллогенной трансплантации гемопоэтических стволовых клеток с деплецией альфа/бетаTCR/CD19+ лимфоцитов у педиатрических пациентов с острыми лейкозами
Аннотация
Об авторах
В.В. ЗахароваРоссия
Ж.Б. Шеховцова
Россия
О.А. Шрагина
Россия
Е.В. Райкина
Россия
М.А. Илюшина
Россия
Я.О. Музалевский
Россия
А.Г. Кочетов
Россия
Л.Н. Шелихова
Россия
М.А. Масчан
Россия
Список литературы
1. McQueen K.L., Parham P. Variable receptors controlling activation and inhibition of NK cells. Current opinion in Immunology 2002; 14: 615-21.
2. Mandelboim O., Reyburn H.T., Vales-Gomez M., et al. Protection from lysis by natural killer cell of group 1 and 2 specificity is mediated by residue 80 in human Histocompatibility Leukocyte Antigen C alleles and also occurs with empty Major Histocompatibility Complex molecules. The Journal of Experimental Medicine 1996; 184: 913-22.
3. Thananchai H., Gillespie G., Martin M.P., et al. Cutting edge: allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. The Journal of Immunol 2007; 178: 33-7.
4. Ljunggren H.G., Karre K. In search of the «missing self»: MHC molecules and NK cell recognition. Immunology today 1990; 11: 237-44.
5. Rugerri L., Capanni M., Casucci M., Volpi I., et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 1999; 94: 333-9.
6. Uhrberg M., Valiante N.M., Shum B.P., et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997; 7: 753-63.
7. Witt C.S., Dewing C.B., Sayer D.C., et al. Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination. Transplantation 1999; 68: 1784-89.
8. Mehra N.K., Kaur G., McCluskey J., et al. The HLA complex in Biology and Medicine: A Resource Book 2010; 31: 526-27.
9. Savani B.N., Mielke S., Adams S., Uribe M., et al. Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia. Leukemia 2007; 21: 2145-52.
10. Maschan M., Shelikhova L., Ilushina M., et al. TCR-alpha/beta and CD19 depletion and threosulfan-based conditioning regimen in unrelated and haploidentical transplantation in children with acute myeloid leukemia. Bone Marrow Transplant 2016; 51 (5): 668-74.
11. Balashov D., Shcherbina A., Maschan M., et. al. Single-center experience of unrelated and haploidentical stem cell transplantation with TCR and CD19 depletion in children with primary immunodeficiency syndromes. Biol Blood Marrow Transplant 2015; 21 (11): 1955-62.
12. Laberko A., Bogoyavlenskaya A., Shelikhova L., et. al. Risk Factors and the Clinical impact of Cytomegalovirus and Epstein-Barr Virus infections in Pediatric Recipients of TCR and CD19-Depleted Grafts. Biol Blood Marrow Transplant 2017; 23 (3): 483-90.
13. Balashov D., Laberko A., Shcherbina A., et. al. A Conditioning Regimen with Plerixafor is Safe and Improves the Outcome of TCR and CD19+-Cell-Depleted Stem Cell Transplantation in Patients with Wiskott-Aldrich Syndrome. Biol Blood Marrow Transplant 2018;(18): 30119-8.
14. http://hla.alleles.org/dictionary/index.html
15. Biassoni R., Vanni I., Ugolotti E. Killerimmunoglobulin-like receptors and their ligands. Histocompatibility book 2012; 6: 97-9.
16. http://www.ebi.ac.uk/ipd/kir
17. Cooley S., Weisdorf D.J., Guethlein L.A., et al. Donor selection for natural killer receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. Blood 2010; 116: 2411-19.
18. Rajalingham R. Overview of the killer cell immunoglobulin-like receptor sys-tem. Methods in Molecular Biology Book 2012; 882: 391-414.
19. Oevermann L., Michaelis S.U., Mezger M., Lang P., et al. KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL. Blood 2014; 124: 2744-7.
20. Torelli G.F., Peragine N., Raponi S., et al. Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cells. Haematologica 2014; 99: 1248-54.
21. Yabe T., Matsuo K., Hirayasu K., et al. Donor killer immunoglobulin-like receptor genotype-patient cognate KIR ligand combination and antithymocyte globulin preadministration are critical factors in outcome of HLA-C-KIR ligand-mismatched T-cell-replete unrelated bone marrow transplantation. Biol Blood Marrow Transplant 2008; 14: 75-87.
22. Cooley S., McCullar V., Wangen R., et al. KIR reconstitution is altered by T-cells in the graft and correlates with clinical outcomes after unrelated donor transplantation. Blood 2005; 106: 4370-76.
Для цитирования:
Захарова В., Шеховцова Ж., Шрагина О., Райкина Е., Илюшина М., Музалевский Я., Кочетов А., Шелихова Л., Масчан М. Влияние аллореактивности естественных киллерных клеток на эффективность аллогенной трансплантации гемопоэтических стволовых клеток с деплецией альфа/бетаTCR/CD19+ лимфоцитов у педиатрических пациентов с острыми лейкозами. Вопросы гематологии/онкологии и иммунопатологии в педиатрии. 2018;17(2):39-50. https://doi.org/10.24287/1726-1708-2018-17-2-39-50
For citation:
Zakharova V.V., Shekhovtsova Z.B., Shragina O.A., Raykina E.V., Ilushina M.A., Muzalevskii Y.O., Kochetov A.G., Shelikhova L.N., Maschan M.A. The Influence of Natural Killer Cell Alloreactivity on the Outcome of α/βTCR/CD19+ depleted Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Leukemia. Pediatric Hematology/Oncology and Immunopathology. 2018;17(2):39-50. (In Russ.) https://doi.org/10.24287/1726-1708-2018-17-2-39-50